540 related articles for article (PubMed ID: 10806139)
1. Effects of terbutaline and budesonide on sputum cells and bronchial hyperresponsiveness in asthma.
Aldridge RE; Hancox RJ; Robin Taylor D; Cowan JO; Winn MC; Frampton CM; Town GI
Am J Respir Crit Care Med; 2000 May; 161(5):1459-64. PubMed ID: 10806139
[TBL] [Abstract][Full Text] [Related]
2. Rebound airway obstruction and responsiveness after cessation of terbutaline: effects of budesonide.
de Jong JW; van der Mark TW; Koëter GH; Postma DS
Am J Respir Crit Care Med; 1996 Jan; 153(1):70-5. PubMed ID: 8542165
[TBL] [Abstract][Full Text] [Related]
3. Comparison of asthma treatment given in addition to inhaled corticosteroids on airway inflammation and responsiveness.
Green RH; Brightling CE; McKenna S; Hargadon B; Neale N; Parker D; Ruse C; Hall IP; Pavord ID
Eur Respir J; 2006 Jun; 27(6):1144-51. PubMed ID: 16455831
[TBL] [Abstract][Full Text] [Related]
4. Effect of an inhaled glucocorticosteroid on mast cell and smooth muscle beta 2 adrenergic tolerance in mild asthma.
Yates DH; Worsdell M; Barnes PJ
Thorax; 1998 Feb; 53(2):110-3. PubMed ID: 9624295
[TBL] [Abstract][Full Text] [Related]
5. Bromotyrosines in sputum proteins and treatment effects of terbutaline and budesonide in asthma.
van Dalen CJ; Aldridge RE; Chan T; Senthilmohan R; Hancox RJ; Cowan JO; Taylor DR; Town GI; Kettle AJ
Ann Allergy Asthma Immunol; 2009 Oct; 103(4):348-53. PubMed ID: 19852201
[TBL] [Abstract][Full Text] [Related]
6. Potential masking effects of salmeterol on airway inflammation in asthma.
Mcivor RA; Pizzichini E; Turner MO; Hussack P; Hargreave FE; Sears MR
Am J Respir Crit Care Med; 1998 Sep; 158(3):924-30. PubMed ID: 9731027
[TBL] [Abstract][Full Text] [Related]
7. Effect of formoterol with or without budesonide in repeated low-dose allergen challenge.
Dahlén B; Lantz AS; Ihre E; Skedinger M; Henriksson E; Jörgensen L; Ekström T; Dahlén SE; Larsson K
Eur Respir J; 2009 Apr; 33(4):747-53. PubMed ID: 19129280
[TBL] [Abstract][Full Text] [Related]
8. Effect of regular terbutaline on the airway response to inhaled budesonide.
Wilding PJ; Clark MM; Oborne J; Bennett JA; Tattersfield AE
Thorax; 1996 Oct; 51(10):989-92. PubMed ID: 8977598
[TBL] [Abstract][Full Text] [Related]
9. An inhaled glucocorticoid does not prevent tolerance to the bronchoprotective effect of a long-acting inhaled beta 2-agonist.
Yates DH; Kharitonov SA; Barnes PJ
Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1603-7. PubMed ID: 8970342
[TBL] [Abstract][Full Text] [Related]
10. Changes in sputum counts and airway hyperresponsiveness after budesonide: monitoring anti-inflammatory response on the basis of surrogate markers of airway inflammation.
Prosperini G; Rajakulasingam K; Cacciola RR; Spicuzza L; Rorke S; Holgate ST; Di Maria GU; Polosa R
J Allergy Clin Immunol; 2002 Dec; 110(6):855-61. PubMed ID: 12464950
[TBL] [Abstract][Full Text] [Related]
11. Randomised trial of an inhaled beta2 agonist, inhaled corticosteroid and their combination in the treatment of asthma.
Hancox RJ; Cowan JO; Flannery EM; Herbison GP; McLachlan CR; Wong CS; Taylor DR
Thorax; 1999 Jun; 54(6):482-7. PubMed ID: 10335000
[TBL] [Abstract][Full Text] [Related]
12. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.
Pauwels RA; Löfdahl CG; Postma DS; Tattersfield AE; O'Byrne P; Barnes PJ; Ullman A
N Engl J Med; 1997 Nov; 337(20):1405-11. PubMed ID: 9358137
[TBL] [Abstract][Full Text] [Related]
13. Bronchodilator tolerance and rebound bronchoconstriction during regular inhaled beta-agonist treatment.
Hancox RJ; Cowan JO; Flannery EM; Herbison GP; McLachlan CR; Taylor DR
Respir Med; 2000 Aug; 94(8):767-71. PubMed ID: 10955752
[TBL] [Abstract][Full Text] [Related]
14. Effect of regular salmeterol treatment on albuterol-induced bronchoprotection in mild asthma.
Yates DH; Worsdell M; Barnes PJ
Am J Respir Crit Care Med; 1997 Sep; 156(3 Pt 1):988-91. PubMed ID: 9310023
[TBL] [Abstract][Full Text] [Related]
15. Effect of regular terbutaline and budesonide on bronchial reactivity to allergen challenge.
Wong CS; Wahedna I; Pavord ID; Tattersfield AE
Am J Respir Crit Care Med; 1994 Nov; 150(5 Pt 1):1268-73. PubMed ID: 7952551
[TBL] [Abstract][Full Text] [Related]
16. Effects of treatment with formoterol on bronchoprotection against methacholine.
Lipworth B; Tan S; Devlin M; Aiken T; Baker R; Hendrick D
Am J Med; 1998 May; 104(5):431-8. PubMed ID: 9626025
[TBL] [Abstract][Full Text] [Related]
17. Effects of budesonide and formoterol on allergen-induced airway responses, inflammation, and airway remodeling in asthma.
Kelly MM; O'Connor TM; Leigh R; Otis J; Gwozd C; Gauvreau GM; Gauldie J; O'Byrne PM
J Allergy Clin Immunol; 2010 Feb; 125(2):349-356.e13. PubMed ID: 19969339
[TBL] [Abstract][Full Text] [Related]
18. T cell activation state in the induced sputum of asthmatics treated with budesonide.
Vatrella A; Perna F; Pelaia G; Parrella R; Maselli R; Marsico SA; Calabrese C
Int J Immunopathol Pharmacol; 2010; 23(3):745-53. PubMed ID: 20943044
[TBL] [Abstract][Full Text] [Related]
19. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma.
Haahtela T; Järvinen M; Kava T; Kiviranta K; Koskinen S; Lehtonen K; Nikander K; Persson T; Selroos O; Sovijärvi A
N Engl J Med; 1994 Sep; 331(11):700-5. PubMed ID: 8058076
[TBL] [Abstract][Full Text] [Related]
20. Short-term treatment with budesonide does not improve hyperresponsiveness to adenosine 5'-monophosphate in COPD.
Rutgers SR; Koëter GH; van der Mark TW; Postma DS
Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):880-6. PubMed ID: 9517606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
